PRODUCT LICENSE AND COLLABORATION AGREEMENTProduct License and Collaboration Agreement • December 4th, 2007 • BG Medicine, Inc. • Services-medical laboratories
Contract Type FiledDecember 4th, 2007 Company IndustryThis Product License and Collaboration Agreement (this “Agreement”) is made and entered into as of this 4 day of May, 2007 (the “Effective Date”), by and between (i) BG Medicine, Inc., a Delaware corporation (“BGM”), (ii) ACS Biomarker B.V. i.o. (“ACSB”), a corporation to be established by the University of Maastricht (the “University”), BioMedbooster B.V., a corporation organized under the laws of The Netherlands (“BioMedbooster”), Yigal Pinto, Mat Daemen, Tilman Hackeng and Marcel Kannekens, and (iii) solely for purposes of Section 3.04 hereof, the University and BioMedbooster.
INTELLECTUAL PROPERTY SECURITY AGREEMENTIntellectual Property Security Agreement • December 4th, 2007 • BG Medicine, Inc. • Services-medical laboratories • California
Contract Type FiledDecember 4th, 2007 Company Industry JurisdictionThis Intellectual Property Security Agreement (this “IP Agreement”) is made as of the 9th day of November, 2007, by and between BG MEDICINE, INC., a Delaware corporation with its principal place of business at 610 Lincoln Street, North Waltham, Massachusetts 02451 (“Grantor”), and SILICON VALLEY BANK, a California-chartered bank, with its principal place of business at 3003 Tasman Drive, Santa Clara, California 95054 and with a loan production office located at One Newton Executive Park, Suite 200, 2221 Washington Street, Newton, Massachusetts 02462 (“Lender”).